Medilink Therapeutics (suzhou) Co., Ltd.

This is the first study in humans testing a new drug called YL242, both alone and in combination with other treatments, for people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to check if the drug is safe, how the body processes …

This study is testing the safety and initial effectiveness of a new two-drug combination (YL201 plus ivonescimab) for people with advanced solid tumors, including specific types of lung cancer. The main goals are to find the safest dose and see if the treatment can shrink tumors.…

This is the first study in people to test a new cancer drug called YL217. The main goals are to check its safety, find the right dose, and see if it can shrink tumors in adults with advanced solid tumors, particularly gastrointestinal cancers. YL217 is a type of targeted therapy …

This study is testing a new drug called YL201, given alone with an immunotherapy drug or with an added chemotherapy, for people with advanced nasopharyngeal cancer that has returned or spread. The main goals are to find a safe dose and see how well the combinations work to contro…

This early-stage study is testing a new drug called YL205 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and get a first look at whether it helps shrink tumors. Th…

This study is testing an experimental drug called YL202 in people with advanced solid tumors, including lung, colorectal, and cervical cancer, that have spread or cannot be removed by surgery. The goal is to see if the drug can shrink tumors and control the disease, and to unders…

This study is testing a new drug called YL202, given alongside other cancer treatments, to see if it is safe and effective for people with advanced solid tumors like breast or lung cancer. The main goals are to find the safest dose and see if the treatment helps shrink tumors. It…

This is the first study in humans testing a new cancer drug called YL201. Researchers want to find the safest dose and see if it helps control advanced solid tumors that haven't responded to standard treatments. The study will test YL201 alone and combined with other cancer thera…

This study is testing an experimental drug called YL202 in people with advanced solid tumors that have spread or can't be removed by surgery. The trial aims to see if YL202 can shrink tumors and control cancer growth while monitoring side effects. It will enroll 200 adults in Chi…

This is the first study in people to test a new cancer drug called YL211. It aims to find a safe dose and see how the body processes the drug in patients with advanced solid tumors that have not responded to standard treatments. The main goals are to check for side effects and se…